|Venue||Hotel Silken Indautxu|
|Address||Plaza Bombero Etxaniz. S/N, Bilbao|
It emphasises the importance of a multidisciplinary approach and of teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based. This will be illustrated during state-of-the-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiotherapists will also be organised during the course.
- To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer
- To discuss patient selection/indications and contra-indications for the various treatment options
- To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer
- To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease
- To debate on the most recent developments relevant to prostate cancer management.
- Normal prostate: anatomy – embryology, histology
- Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging
- Low risk prostate cancer: active surveillance, surgery and the postop pathology
- Radiotherapy and brachytherapy, the pathology after irradiation
- External beam radiotherapy: on-line control, target delineation
- High risk prostate cancer: radiotherapy and hormones, alternative radiotherapy regimens
- Toxicity of radiotherapy: acute and late morbidity – erectile dysfunction
- Role of surgery and its morbidity
- Alternative treatments
- Adjuvant and salvage radiotherapy after radical surgery
- Rising PSA after surgery and after radiotherapy
- Imaging for recurrent detection
- Node positive prostate cancer
- Metastatic prostate cancer: hormones and their complications
- Castration resistant prostate cancer: new drugs
- Palliative radiotherapy and surgery
- Non systemic treatment in the metastatic setting.
- Case Discussions
Before commencing this course participants should:
- Revise the general principles of prostate cancer epidemiology, pathology, diagnosis and staging
- Read the published ESTRO and ASTRO guidelines on prostate contouring and the EAU/ESTRO/SIOG/EANM/ESUR guidelines on prostate cancer
- Complete the FALCON* exercise which is distributed prior to the course.
- 21 hours lectures
- 3 hours contouring
- 4 hours practical workshops
- 5 hours interactive discussions.
The course consists of didactic lectures, interactive sessions (clinical case discussions and Journal Clubs) and practical demonstrations.
Methods of assessment
- In-class voting
- Delineation exercise
Contact our organiser